Stockscreener 앱 받기
6.51
8.14%
0.49
시간 외 거래:
6.66
0.15
+2.30%
전일 마감가:
$6.02
열려 있는:
$6.02
하루 거래량:
182.78K
Relative Volume:
1.25
시가총액:
$42.30M
수익:
$16.03M
순이익/손실:
$-18.83M
주가수익비율:
-1.86
EPS:
-3.5
순현금흐름:
$-14.87M
1주 성능:
+10.71%
1개월 성능:
-18.63%
6개월 성능:
-27.51%
1년 성능:
+15.22%
1일 변동 폭
$6.02
$7.07
1주일 범위
$5.57
$7.07
52주 변동 폭
$5.02
$19.49
Electrocore Inc Stock (ECOR) Company Profile
명칭
Electrocore Inc
전화
973-290-0097
주소
200 FORGE WAY, ROCKAWAY
ECOR을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
ECOR
Electrocore Inc
|
6.51 | 42.30M | 16.03M | -18.83M | -14.87M | -3.50 |
|
ABT
Abbott Laboratories
|
129.89 | 221.92B | 41.95B | 13.40B | 6.35B | 7.65 |
|
BSX
Boston Scientific Corp
|
93.58 | 139.43B | 16.75B | 1.85B | 2.37B | 1.25 |
|
SYK
Stryker Corp
|
339.59 | 134.90B | 22.60B | 2.99B | 3.49B | 7.76 |
|
MDT
Medtronic Plc
|
81.80 | 104.24B | 33.20B | 4.26B | 5.47B | 3.29 |
|
EW
Edwards Lifesciences Corp
|
69.20 | 40.93B | 5.72B | 4.17B | 259.90M | 6.97 |
Electrocore Inc Stock (ECOR) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2020-08-14 | 업그레이드 | BTIG Research | Neutral → Buy |
| 2019-11-14 | 다운그레이드 | JMP Securities | Mkt Outperform → Mkt Perform |
| 2019-09-26 | 재개 | Cantor Fitzgerald | Neutral |
| 2019-05-30 | 다운그레이드 | Cantor Fitzgerald | Overweight → Neutral |
| 2019-05-15 | 다운그레이드 | BTIG Research | Buy → Neutral |
| 2019-05-09 | 개시 | Noble Capital Markets | Outperform |
| 2018-09-21 | 개시 | Cantor Fitzgerald | Overweight |
모두보기
Electrocore Inc 주식(ECOR)의 최신 뉴스
ElectroCore (ECOR) Reports Positive Outcomes for Traumatic Brain Injury Treatment | ECOR Stock News - GuruFocus
electroCore announces new data presented on nVNS - TipRanks
electroCore, Inc. Reports Positive Data on gammaCore® for Treating Concussive Symptoms in Mild Traumatic Brain Injury at 2025 IBIA World Congress - Nasdaq
gammaCore Non-Invasive Vagus Nerve Stimulation (nVNS) Shown to be Effective in Treating Concussive Symptoms Associated with Mild Traumatic Brain Injuries - GlobeNewswire
Breakthrough Study: Non-Invasive Brain Treatment Relieves 22 Concussion Symptoms in Major Clinical Trial - Stock Titan
electroCore to Participate at the Planet MicroCap Showcase - GlobeNewswire
Vagus Nerve Stimulators Market Deep Research Report with - openPR.com
Electrocore at 24th Annual Needham Virtual Healthcare Conference: Strategic Expansion Plans - Investing.com Australia
ElectroCore stock hits 52-week low at $5.3 amid challenges - Investing.com
ElectroCore stock hits 52-week low at $5.3 amid challenges By Investing.com - Investing.com South Africa
electroCore appoints new independent accounting firm By Investing.com - Investing.com Australia
electroCore appoints new independent accounting firm - Investing.com
electroCore Named One of The Americas’ Fastest Growing Companies by the Financial Times - GlobeNewswire
Financial Times Names electroCore #16 Fastest-Growing Healthcare Company in Americas - Stock Titan
Vagus Nerve Stimulators Market Size, Growth Trends and Report - openPR.com
electroCore to Participate at the Needham Virtual Healthcare Conference - The Manila Times
electroCore Showcases Breakthrough Bioelectronic Medicine Platform: CEO Headlines Needham Conference - Stock Titan
NeuroMetrix, Inc. SEC 10-K Report - TradingView
electroCore secures new VA contract through 2030 - Investing.com India
electroCore secures new VA contract through 2030 By Investing.com - Investing.com UK
electroCore Extends VA Contract for Five Years - GlobeNewswire
electroCore Wins Massive VA Deal While 585 Others Get Cut - Stock Titan
(ECOR) Technical Data - news.stocktradersdaily.com
NeuroMetrix shareholders approve merger with electroCore By Investing.com - Investing.com Australia
Market Cool On electroCore, Inc.'s (NASDAQ:ECOR) Revenues Pushing Shares 59% Lower - simplywall.st
NeuroMetrix shareholders approve merger with electroCore - Investing.com
Insider Buying: Thomas Errico Acquires 6,000 Shares of electroCo - GuruFocus.com
Trend Tracker for (ECOR) - news.stocktradersdaily.com
Vagus Nerve Stimulators Market is Expected to Witness Positive Growth With A CAGR of 9.06% by 2030, estimates DelveInsight - The Globe and Mail
Vagus Nerve Stimulators Market is Expected to Witness Positive - openPR.com
electroCore CEO Daniel Goldberger acquires $8,590 in stock By Investing.com - Investing.com Australia
electroCore CEO Daniel Goldberger acquires $8,590 in stock - Investing.com India
While shareholders of electroCore (NASDAQ:ECOR) are in the black over 1 year, those who bought a week ago aren't so fortunate - Simply Wall St
Q1 Earnings Estimate for electroCore Issued By HC Wainwright - Defense World
electroCore (NASDAQ:ECOR) Earns “Buy” Rating from HC Wainwright - Defense World
electroCore FY2028 EPS Forecast Increased by HC Wainwright - Defense World
LADENBURG THALM/SH SH Has Lowered Expectations for electroCore (NASDAQ:ECOR) Stock Price - Defense World
Earnings call transcript: ElectroCore Q4 2024 sees revenue rise, stock dips By Investing.com - Investing.com South Africa
H.C. Wainwright maintains Buy on electroCore stock, $25 target By Investing.com - Investing.com India
electroCore, Inc. (NASDAQ:ECOR) Q4 2024 Earnings Call Transcript - Insider Monkey
12 Health Care Stocks Moving In Thursday's Pre-Market Session - Benzinga
H.C. Wainwright maintains Buy on electroCore stock, $25 target - Investing.com
electroCore Inc (ECOR) Q4 2024 Earnings Call Highlights: Strong Revenue Growth and Strategic ... - Yahoo Finance
ElectroCore Reports Strong 2024 Financial Growth - TipRanks
ElectroCore, Inc. (ECOR) Reports Q4 Loss, Lags Revenue Estimates - Yahoo Finance
Electrocore Inc (ECOR) 재무 분석
매출
순이익
현금흐름
주당 순 이익
1.79%
자본화:
|
볼륨(24시간):